# Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma

> **NCT01924819** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Australasian Gastro-Intestinal Trials Group** · enrollment: 574 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** Epirubicin + cisplatin + 5-fluorouracil OR epirubicin + cisplatin + capecitabine OR epirubicin + oxaliplatin + capecitabine OR 5-Fluorouracil + leucovorin + oxaliplatin + docetaxel
- **RADIATION:** Preoperative chemoradiotherapy
- **PROCEDURE:** Gastric resection

## Key facts

- **NCT ID:** NCT01924819
- **Lead sponsor:** Australasian Gastro-Intestinal Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2009-09
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 574 (ACTUAL)
- **Last updated:** 2025-03-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01924819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01924819, "Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01924819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*